Pharmafile Logo

Cancer therapy

- PMLiVE

AI-Driven Platforms Enhance Drug Discovery Collaborations

Generative AI platforms are revolutionizing drug discovery, driving significant biopharma dealmaking by enabling the design of innovative small-molecule and biologic drug candidates.

Springer Nature

- PMLiVE

Eli Lilly and Radionetics Oncology enter $140m radiopharma partnership

The strategic agreement also gives Lilly the exclusive right to acquire the biotech for $1bn

- PMLiVE

Hope in cancer therapy

The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.

Springer Nature

- PMLiVE

Half of European cancer drug trials ‘biased’, says BMJ

Report says studies exaggerate benefits

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links